Allergan rose$. 58 or. 5 percent, to $128.34. Baxter International Inc. fell$. 48 or. 7 percent, to $66.49. Boston Scientific Corp. rose$. 27 or 2.1 percent, to $13.01.» Read More
A detailed look at how a tax on medical devices divided so many over the White House's Affordable Care Act.
BRUSSELS, Sept 25- European Union lawmakers backed a strict new approval system for high-tech medical devices on Wednesday, raising industry fears of added delays in getting new products to market that could dull Europe's competitive edge.
*Stryker to pay $30/ Mako share, 86 pct premium to last close. Sept 25- Medical device maker Stryker Corp will buy smaller peer Mako Surgical Corp for about $1.65 billion to gain access to Mako's technology for robot-assisted orthopedic surgery. Mako shares jumped 83 percent at $29.57 in morning trade, just shy of the offer price Of $30 per share.
Sept 25- Medical device maker Stryker Corp will buy smaller peer Mako Surgical Corp for about $1.65 billion to gain access to Mako's technology for robot-assisted orthopedic surgery.
JPMorgan Chase, the Bill & Melinda Gates Foundation and others have launched an investment fund focused on late-stage healthcare technology trials.
Jeffrey Shuren, director of the FDA's medical device division, said. The FDA plans to phase in the UDI system over several years, focusing first on medical devices that carry the greatest risk to patients such as pacemakers, defibrillators, heart pumps and artificial joints.
The FDA will enter the unique device identifier, or UDI codes, into a database that the agency will maintian as a publicly searchable reference catalogue. The FDA plans to phase in the UDI system, focusing first on medical devices that carry the greatest risk to patients such as pacemakers, defibrillators, heart pumps and artificial joints.
Sept 20- Becton Dickinson and Co said it may have to pay up to $340 million after a federal jury found the medical device maker guilty of attempting to monopolize the safety syringe market through deceptive practices. The jury in a Texas district court awarded $113.5 million to safety syringes maker Retractable Technologies Inc, which filed the lawsuit.
Sept 19- Medical device maker Covidien Plc said it would cut costs by outsourcing services to low-cost locations and consolidating manufacturing and distribution centers. The company said it expects to record related charges of about $350 million to $450 million, most of which will be incurred by the end of fiscal 2018..
LONDON, Sept 19- A 90- year-old helium reservoir in Texas could shut down next month causing disruptions and raising costs for makers of high-tech products from MRI scanners to semiconductors and threaten medical treatments and research.
A research project that gathers more information from hospital monitors than ever before is improving the prognosis of premature infants.
A new Web company is offering to connect inventors of smaller medical devices with people who can give them the cash they need to get off the ground.
Community Health Systems announced it would buy Health Management Associates in a deal valued at approximately $7.6 billion, including about $3.7 billion in debt.
Intuitive Surgical is down about 18 percent today after pre-announcing a huge miss Monday, CNBC's Herb Greenberg brings everyone up to speed; and Jason Mills, analyst at Canaccord Genuity, explains why he downgraded the stock.
Jim Cramer believes this company is about to create immense value with the stroke of a pen.
When architect Michael Graves realized he would spend the rest of his life in a wheelchair, he set out to improve medical design. This week Stryker unveils his wheelchair.
Bristol-Myers Squibb and Merck stocks climbed higher Monday as analysts said billions stood to be made from treatment breakthroughs.
Americans accustomed to immediate access to the newest technology may be shocked to find that is not the case when it comes to devices that treat ailing hearts.
Cramer’s convinced the best way to for this health care company to maximize shareholder value is to break up.
The rise of "superbugs," and pressure from the government and insurers, is driving hospitals to try all sorts of new approaches to stop their spread.